Supplementary Table 2 from Molecular Profiling Establishes Genetic Features Predictive of the Efficacy of the p110β Inhibitor KIN-193

PTEN null resistant cell-lines that have a mutation in PIK3CB or PIK3R1. Columns 1:3 give information about cell-line and columns 4:8 give details about the mutation.